Wagner Wealth Management (South Carolina)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-539
Closed -$18K 262
2022
Q3
$18K Sell
539
-205
-28% -$7.53K 0.01% 329
2022
Q2
$23K Buy
+744
New +$26K 0.02% 304
2022
Q1
Sell
-3,571
Closed -$219K 232
2021
Q4
$219K Sell
3,571
-60
-2% -$4.15K 0.17% 114
2021
Q3
$273K Sell
3,631
-6,340
-64% -$532K 0.22% 89
2021
Q2
$922K Sell
9,971
-873
-8% -$74.2K 0.66% 42
2021
Q1
$962K Buy
10,844
+856
+9% +$84.9K 0.76% 33
2020
Q4
$931K Buy
+9,988
New +$796K 0.88% 34

Other funds holding ARKG

Wagner Wealth Management (South Carolina)'s ARKG Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 539 shares — an estimated $18K sold.

Wagner Wealth Management (South Carolina) first reported a position in ARKG in Q4 2020 and held it in 7 quarters. The position peaked at $962K in Q1 2021. 320 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 539 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $18K.
  • Wagner Wealth Management (South Carolina) first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 7 quarters.
  • Wagner Wealth Management (South Carolina)'s ARK Genomic Revolution ETF position peaked at $962K in Q1 2021.
  • 320 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.